Home > > > > Report Detail

Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel B2C (Patient, Caregiver), B2B ( Providers, Payer, Employer, Pharma) - Global Forecasts to 2027

Publisher Name :
Date: 21-Oct-2022
No. of pages: 231
Inquire Before Buying

“Digital therapeutics market to register a CAGR of 31.6 % from 2022 to 2027”

The global digital therapeutics market is projected to reach USD 17.7 billion by 2027 from USD 4.5 billion in 2022, at a CAGR of 31.6% during the forecast period. The adoption of digital therapeutics is growing at a fast pace owing to factors such as rise in number of patients with chronic diseases and growing investments in digital therapeutics. However, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and uneven payment models are challenging the growth of this market.

Treatment/care-related applications segment hold the largest share of the digital therapeutics market in 2021

On the basis of application, the digital therapeutics market is divided into preventive and treatment/care-related applications. The large share of this segment is attributed to the rising investments in digital therapeutics to promote the development of cost-effective and scalable treatment platforms for these conditions.

Diabetes segment is expected to grow at the highest rate during the forecast period

On the basis of type of treatment/care-related application, the digital therapeutics market is further divided into diabetes, CNS disorders, chronic respiratory diseases, musculoskeletal disorders, cardiovascular diseases, smoking cessation, medication adherence, gastrointestinal disorders, substance use disorders & addiction management, rehabilitation & patient care, and other treatment/care-related applications. In 2021, diabetes commanded the largest share of the digital therapeutics market for treatment/care-related applications. The increasing prevalence of diabetes, high healthcare costs associated with diabetes, and rising government initiatives to decrease the burden with the help of cost-effective solutions are expected to drive the market growth in this segment.

B2B segment is expected to grow with the highest CAGR during the forecast period

On the basis of sales channel, the digital therapeutics market is divided into business-to-customer (B2C) and business-to-business (B2B). This is attributed to growing inclination of pharma companies to integrate digital therapeutics with their drug products.

North America to be the largest and the fastest-growing regional market

North America, which includes the US and Canada, holds the largest market share for digital therapeutics in 2021. Factors such as the improvements in the reimbursement structure for digital therapeutics, and government initiatives to support technological advancements drive market growth in this region.

The primary interviews conducted for this report can be categorized as follows:


  • By Company Type: Tier 1 (50%), Tier 2 (30%), and Tier 3 (20%)

  • By Designation: C-level (75%), D-level (15%), and Others (10%)

  • By Region: North America (70%), Europe (20%), APAC (7%), and the RoW (3%)


The prominent players in this market are Noom, Inc (US), Teladoc Health, Inc. (US), Omada Health, Inc. (US), WellDoc, Inc (US), Pear Therapeutics, Inc. (US), CogniFit Inc (US), Ginger (US), Propeller Health (US), 2Morrow, Inc. (US), Canary Health (US), Click Therapeutics, Inc. (US), Akili, Inc. (US), Cognoa, Inc (US), Wellthy Therapeutics Pvt. Ltd. (India), Twill Inc. (US), Better Therapeutics, Inc (US), Mindstrong (US), Kaia Health (Germany), BehaVR Inc (US), Ayogo (Canada), Mindable Health GmbH (Germany), Virta Health Corp (US), Hinge Health, Inc. (US), Orexo AB (Sweden) and Freespira (US).

Research Coverage:

This report provides a study of the digital therapeutics market. It aims at estimating the size and future growth potential of the market across different segments, such as sales channel, application, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of revenue numbers for the overall digital therapeutics market and its subsegments. This report will also help stakeholders understand the competitive landscape, gain insights to position their business, and make suitable go-to-market strategies. It will also enable stakeholders to gauge the pulse of the market and provide them with information on the key market drivers, restraints, opportunities and challenges.

Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel B2C (Patient, Caregiver), B2B ( Providers, Payer, Employer, Pharma) - Global Forecasts to 2027

Table Of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions And Exclusions
1.3 Market Scope
1.4 Years Considered
1.5 Currency Considered
1.6 Stakeholders
1.7 Limitations
1.8 Summary Of Changes

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
Figure 2 Primary Sources
2.1.2.1 Key Data From Primary Sources
Figure 3 Key Industry Insights
Figure 4 Breakdown Of Primary Interviews (Supply Side): By Companytype, Designation, And Region
Figure 5 Breakdown Of Primary Interviews (Demand Side): By Type Of Buyer And Region
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.1.1 Approach One: Revenue Mapping-Based Estimation
Figure 6 Digital Therapeutics: Revenue Mapping-Based Estimation
2.2.1.2 Approach Two: Buyer Adoption-Based Estimation
Figure 7 Digital Therapeutics Estimation: Buyer Adoption-Based Estimation
2.2.2 Top-Down Approach: Paenetration Rate-Based Market Size Estimation
Figure 8 Penetration Rate-Based Market Estimation
2.2.3 Growth Forecast
Table 1 Factor Analysis
Figure 9 Cagr Projections From Analysis Of Drivers, Restraints, Opportunities, And Challenges (2022–2027)
Figure 10 Cagr Projections: Supply-Side Analysis
2.3 Market Breakdown And Data Triangulation
Figure 11 Data Triangulation Methodology
2.4 Assumptions
2.5 Risk Assessment

3 Executive Summary
Figure 12 Digital Therapeutics Market, By Sales Channel, 2022 Vs. 2027 (Usd Million)
Figure 13 Digital Therapeutics Market For B2c Sales Channel, 2022 Vs. 2027 (Usd Million)
Figure 14 Digital Therapeutics Market For B2b Sales Channel, 2022–2027
Figure 15 Digital Therapeutics Market, By Application (2022–2027)
Figure 16 Digital Therapeutics Market For Treatment/Care-Related Applications, 2022 Vs. 2027 (Usd Million)
Figure 17 Geographical Snapshot Of Digital Therapeutics Market

4 Premium Insights
4.1 Digital Therapeutics Market Overview
Figure 18 Increasing Incidence Of Chronic Diseases & Technological Advancements To Drive Adoption Of Digital Therapeutics
4.2 Digital Therapeutics Market, By Sales Channel, 2022–2027
Figure 19 B2b Sales Dominate Digital Therapeutics Market
4.3 Digital Therapeutics Market: Geographic Growth Opportunities
Figure 20 North America To Grow At Highest Rate

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 21 Digital Therapeutics Market: Drivers, Restraints, Opportunities, And Challenges
5.2.1 Drivers
5.2.1.1 Increasing Incidence Of Preventable Chronic Diseases
5.2.1.2 Rising Focus On Preventive Healthcare
5.2.1.3 Need To Control Healthcare Costs
5.2.1.4 Significant Increase In Venture Capital Investments
5.2.1.5 Benefits Of Digital Therapeutics
5.2.1.5.1 Ability To Induce Behavioral Change
5.2.1.5.2 Improved Drug Adherence
5.2.1.5.3 Patient Convenience And User-Friendliness
5.2.2 Restraints
5.2.2.1 Patient Data Privacy Concerns
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Large Undiagnosed And Untreated Population
5.2.3.3 Unexplored Therapeutic Applications
5.2.4 Challenges
5.2.4.1 Unstable Payment Models
5.2.4.2 Reluctance Among Patients To Adopt Digital Therapeutics
5.2.4.3 Lack Of Awareness And Access To Digital Therapeutics Programs In Developing Countries
5.2.4.4 Resistance From Traditional Healthcare Providers
5.3 Supply/Value Chain Analysis
Figure 22 Value Chain Analysis
5.4 Ecosystem Analysis
Figure 23 Ecosystem Analysis
5.5 Pipeline Products
5.6 Case Studies
5.7 Porter’s Five Forces Analysis
5.7.1 Threat Of New Entrants
5.7.2 Bargaining Power Of Suppliers
5.7.3 Bargaining Power Of Buyers
5.7.4 Threat Of Substitutes
5.7.5 Intensity Of Competitive Rivalry
5.8 Regulatory Landscape
5.8.1 Regulatory Bodies, Government Agencies, And Other Organizations
Table 2 Digital Therapeutics Regulatory Framework
Table 3 Digital Therapeutics Market: Regulatory Data Needed For Class Iidevices
5.9 Technology Trends
Table 4 Technology Enablers, Benefits, And Examples
5.10 Industry Trends
5.10.1 Virtual Reality
5.10.2 Increasing Demand For Digital Delivery Of Behavioral Therapy
5.10.3 Growing Collaborations Between Stakeholders
Table 5 Digital Therapeutics: Recent Collaborations
5.11 Pricing Analysis & Reimbursement Scenario
5.11.1 Average Selling Price
Table 6 Digital Therapeutics Products: Reimbursement & Price By Country
5.11.2 Reimbursement Scenario
Table 7 Digital Therapeutics: Global Coverage Determination Standards
5.12 Patent Analysis
5.13 Key Conferences And Events In 2022–2023
Table 8 Digital Therapeutics Market: Detailed List Of Conferences And Events
5.14 Key Stakeholders And Buying Criteria
5.14.1 Key Stakeholders In Buying Process
Figure 24 Influence Of Stakeholders In Buying Process For Sales Channel
Table 9 Influence Of Stakeholders In Buying Process For Sales Channel
5.14.2 Buying Criteria
Figure 25 Key Buying Criteria For Sales Channel
Table 10 Key Buying Criteria For Sales Channel

6 Digital Therapeutics Market, By Application
6.1 Introduction
Table 11 Digital Therapeutics Market, By Application, 2020–2027 (Usd Million)
6.2 Treatment/Care-Related Applications
Table 12 Digital Therapeutics Market For Treatment/Care-Related Applications, Bytype, 2020–2027 (Usd Million)
Table 13 Digital Therapeutics Market For Treatment/Care-Related Applications, Byregion, 2020–2027 (Usd Million)
6.2.1 Diabetes
6.2.1.1 Rising Prevalence Of Diabetes To Drive Market Growth
Table 14 Digital Therapeutics Market For Diabetes, By Region, 2020–2027(Usd Million)
6.2.2 Central Nervous System Disorders
Table 15 Digital Therapeutics Market For Cns Disorders, By Type, 2020–2027(Usd Million)
Table 16 Digital Therapeutics Market For Cns Disorders, By Region, 2020–2027(Usd Million)
6.2.2.1 Mental Health Disorders
6.2.2.1.1 Benefits Of Digital Therapeutics In Managing Mental Health Disorders To Drive R&D
Table 17 Digital Therapeutics Market For Mental Healthdisorders, By Region, 2020–2027 (Usd Million)
6.2.2.2 Other Cns Disorders
Table 18 Digital Therapeutics Market For Other Cns Disorders, Byregion, 2020–2027 (Usd Million)
6.2.3 Smoking Cessation
6.2.3.1 Focus On Providing Validated, Effective Mobile Applications To Help Quit Smoking To Aid Marketgrowth
Table 19 Digital Therapeutics Market For Smoking Cessation, By Region,2020–2027 (Usd Million)
6.2.4 Chronic Respiratory Diseases
6.2.4.1 Growing Prevalence Of Copd And Asthma To Drive Market Growth
Table 20 Digital Therapeutics Market For Chronic Respiratorydiseases, By Region, 2020–2027 (Usd Million)
6.2.5 Musculoskeletal Disorders
6.2.5.1 Dearth Of Physiotherapists To Support Market Growth
Table 21 Digital Therapeutics Market For Musculoskeletal Disorders,By Region, 2020–2027 (Usd Million)
6.2.6 Cardiovascular Disease
6.2.6.1 High Burden Of Cvd To Drive Demand For Digital Therapeutics Solutions
Table 22 Digital Therapeutics Market For Cvd, By Region, 2020–2027 (Usdmillion)
6.2.7 Medication Adherence
6.2.7.1 Growing Number Of Medication Non-Adherence Cases To Propel Market Growth
Table 23 Digital Therapeutics Market For Medication Adherence, Byregion, 2020–2027 (Usd Million)
6.2.8 Gastrointestinal Disorders
6.2.8.1 High Prevalence Of Gastrointestinal Disorders To Ensure Strong Interest In Developing Targetedsolutions
Table 24 Digital Therapeutics Market For Gastrointestinal Disorders,By Region, 2020–2027 (Usd Million)
6.2.9 Rehabilitation & Patient Care
6.2.9.1 Benefits Of Digital Therapeutics Have Induced Startups To Develop Platforms For Patient Care
Table 25 Digital Therapeutics Market For Rehabilitation & Patient Care, By Region, 2020–2027 (Usd Million)
6.2.10 Substance Use Disorders & Addiction Management
6.2.10.1 Potential To Improve Efficiency Of Behavioral Interventions To Drive Market Growth
Table 26 Digital Therapeutics Market For Substance Use Disorders &Addiction Management, By Region, 2020–2027 (Usd Million)
6.2.11 Other Treatment/Care-Related Applications
Table 27 Digital Therapeutics Market For Other Treatment/Care-Relatedapplications, By Region, 2020–2027 (Usd Million)
6.3 Preventive Applications
Table 28 Digital Therapeutics Market For Preventive Applications, By Type, 2020–2027 (Usd Million)
Table 29 Digital Therapeutics Market For Preventive Applications, By Region, 2020–2027 (Usd Million)
6.3.1 Prediabetes
6.3.1.1 Influx Of Startups To Provide Effective Prevention Against Prediabetes To Support Market
Table 30 Digital Therapeutics Market For Prediabetes, By Region, 2020–2027 (Usd Million)
6.3.2 Obesity
6.3.2.1 Availability Of Cost-Effective Solutions For Obesity Management To Propel Market Growth
Table 31 Digital Therapeutics Market For Obesity, By Region, 2020–2027(Usd Million)
6.3.3 Nutrition
6.3.3.1 Importance Of Nutrition In Preventing A Wide Range Of Ailments To Drive Demand For Digitaltherapeutic Solutions
Table 32 Digital Therapeutics Market For Nutrition, By Region, 2020–2027(Usd Million)
6.3.4 Lifestyle Management
6.3.4.1 Ability Of Digital Therapeutics Solutions To Induce Positive Behavioral Changes To Contribute Torising Demand
Table 33 Digital Therapeutics Market For Lifestyle Management, Byregion, 2020–2027 (Usd Million)
6.3.5 Other Preventive Applications
Table 34 Digital Therapeutics Market For Other Preventive Applications, Byregion, 2020–2027 (Usd Million)

7 Digital Therapeutics Market, By Sales Channel
7.1 Introduction
Table 35 Digital Therapeutics Market, By Sales Channel, 2020–2027 (Usd Million)
7.2 B2b
Table 36 Digital Therapeutics Market For B2b Sales Channel, By Buyer, 2020–2027(Usd Million)
Table 37 Digital Therapeutics Market For B2b Sales Channel, By Region, 2020–2027(Usd Million)
7.2.1 Payers
7.2.1.1 Payers To Hold Largest Share Of B2b Market
Table 38 Digital Therapeutics Market For Payers, By Region, 2020–2027(Usd Million)
7.2.2 Employers
7.2.2.1 Rising Importance Of Employee Health Management To Drive Adoption Of Digital Therapeuticsamong Employers
Table 39 Digital Therapeutics Market For Employers, By Region, 2020–2027 (Usd Million)
7.2.3 Pharmaceutical Companies
7.2.3.1 Growing Cross-Industry Collaborations Between Digital Therapeutics Start-Ups Andpharmaceutical Companies To Drive Market Growth
Table 40 Digital Therapeutics Market For Pharmaceutical Companies, Byregion, 2020–2027 (Usd Million)
7.2.4 Providers
7.2.4.1 Potential For Better Patient Management And Cost-Reduction To Drive Demand For Digitaltherapeutics Among Providers
Table 41 Digital Therapeutics Market For Providers, By Region, 2020–2027 (Usd Million)
7.2.5 Other Buyers
Table 42 Digital Therapeutics Market For Other Buyers, By Region, 2020–2027(Usd Million)
7.3 B2c
Table 43 Digital Therapeutics Market For B2c Sales Channel, By Buyer, 2020–2027(Usd Million)
Table 44 Digital Therapeutics Market For B2c Sales Channel, By Region, 2020–2027(Usd Million)
7.3.1 Caregivers
7.3.1.1 Ease Of Managing Health Conditions To Drive Demand For Solutions Among Caregivers
Table 45 Digital Therapeutics Market For Caregivers, By Region, 2020–2027 (Usd Million)
7.3.2 Patients
7.3.2.1 Awareness Of Preventive Health Among Patients To Support Segment Growth
Table 46 Digital Therapeutics Market For Patients, By Region, 2020–2027(Usd Million)

8 Digital Therapeutics Market, By Region
8.1 Introduction
Table 47 Digital Therapeutics Market, By Region, 2020–2027 (Usd Million)
8.2 North America
Figure 26 North America: Digital Therapeutics Market Snapshot
Table 48 North America: Digital Therapeutics Market, By Country, 2020–2027 (Usdmillion)
Table 49 North America: Digital Therapeutics Market, By Application, 2020–2027 (Usdmillion)
Table 50 North America: Digital Therapeutics Market For Treatment/Care-Relatedapplications, By Type, 2020–2027 (Usd Million)
Table 51 North America: Digital Therapeutics Market For Preventive Applications,By Type, 2020–2027 (Usd Million)
Table 52 North America: Digital Therapeutics Market For Cns Disorders, By Type,2020–2027 (Usd Million)
Table 53 North America: Digital Therapeutics Market, By Sales Channel, 2020–2027(Usd Million)
Table 54 North America: Digital Therapeutics Market For B2c Sales Channel, Bybuyer, 2020–2027 (Usd Million)
Table 55 North America: Digital Therapeutics Market For B2b Sales Channel, Bybuyer, 2020–2027 (Usd Million)
8.2.1 Us
8.2.1.1 Strong Start-Up Base To Ensure High Product Access For End Users
Table 56 Us: Digital Therapeutics Market, By Application, 2020–2027 (Usdmillion)
Table 57 Us: Digital Therapeutics Market For Treatment/Care-Relatedapplications, By Type, 2020–2027 (Usd Million)
Table 58 Us: Digital Therapeutics Market For Preventive Applications,By Type, 2020–2027 (Usd Million)
Table 59 Us: Digital Therapeutics Market For Cns Disorders, By Type,2020–2027 (Usd Million)
Table 60 Us: Digital Therapeutics Market, By Sales Channel, 2020–2027(Usd Million)
Table 61 Us: Digital Therapeutics Market For B2c Sales Channel, Bybuyer, 2020–2027 (Usd Million)
Table 62 Us: Digital Therapeutics Market For B2b Sales Channel, Bybuyer, 2020–2027 (Usd Million)
8.2.2 Canada
8.2.2.1 Government Initiatives To Support Digital Therapeutics To Drive Market Growth In Canada
Table 63 Canada: Digital Therapeutics Market, By Application, 2020–2027(Usd Million)
Table 64 Canada: Digital Therapeutics Market For Treatment/Care-Related Applications, By Type, 2020–2027 (Usd Million)
Table 65 Canada: Digital Therapeutics Market For Preventiveapplications, By Type, 2020–2027 (Usd Million)
Table 66 Canada: Digital Therapeutics Market For Cns Disorders, Bytype, 2020–2027 (Usd Million)
Table 67 Canada: Digital Therapeutics Market, By Sales Channel, 2020–2027 (Usd Million)
Table 68 Canada: Digital Therapeutics Market For B2c Sales Channel, Bybuyer, 2020–2027 (Usd Million)
Table 69 Canada: Digital Therapeutics Market For B2b Sales Channel, Bybuyer, 2020–2027 (Usd Million)
8.3 Europe
Figure 27 Europe: Digital Therapeutics Market Snapshot
Table 70 Europe: Digital Therapeutics Market, By Country, 2020–2027 (Usd Million)
Table 71 Europe: Digital Therapeutics Market, By Application, 2020–2027 (Usdmillion)
Table 72 Europe: Digital Therapeutics Market For Treatment/Care-Relatedapplications, By Type, 2020–2027 (Usd Million)
Table 73 Europe: Digital Therapeutics Market For Preventive Applications, Bytype, 2020–2027 (Usd Million)
Table 74 Europe: Digital Therapeutics Market For Cns Disorders, By Type, 2020–2027(Usd Million)
Table 75 Europe: Digital Therapeutics Market, By Sales Channel, 2020–2027 (Usdmillion)
Table 76 Europe: Digital Therapeutics Market For B2c Sales Channel, By Buyer,2020–2027 (Usd Million)
Table 77 Europe: Digital Therapeutics Market For B2b Sales Channel, By Buyer,2020–2027 (Usd Million)
8.3.1 Germany
8.3.1.1 Germany Forms Largest Market For Digital Therapeutics In Europe Due To Supportivegovernment Initiatives
Table 78 Germany: Digital Therapeutics Market, By Application, 2020–2027(Usd Million)
Table 79 Germany: Digital Therapeutics Market For Treatment/Care-Related Applications, By Type, 2020–2027 (Usd Million)
Table 80 Germany: Digital Therapeutics Market For Preventiveapplications, By Type, 2020–2027 (Usd Million)
Table 81 Germany: Digital Therapeutics Market For Cns Disorders, By
Type, 2020–2027 (Usd Million)
Table 82 Germany: Digital Therapeutics Market, By Sales Channel, 2020–2027 (Usd Million)
Table 83 Germany: Digital Therapeutics Market For B2c Sales Channel,By Buyer, 2020–2027 (Usd Million)
Table 84 Germany: Digital Therapeutics Market For B2b Sales Channel,By Buyer, 2020–2027 (Usd Million)
8.3.2 Uk
8.3.2.1 Well-Established Healthcare System And Government Support To Propel Market
Table 85 Uk: Digital Therapeutics Market, By Application, 2020–2027 (Usdmillion)
Table 86 Uk: Digital Therapeutics Market For Treatment/Care-Relatedapplications, By Type, 2020–2027 (Usd Million)
Table 87 Uk: Digital Therapeutics Market For Preventive Applications,By Type, 2020–2027 (Usd Million)
Table 88 Uk: Digital Therapeutics Market For Cns Disorders, By Type,2020–2027 (Usd Million)
Table 89 Uk: Digital Therapeutics Market, By Sales Channel, 2020–2027(Usd Million)
Table 90 Uk: Digital Therapeutics Market For B2c Sales Channel, Bybuyer, 2020–2027 (Usd Million)
Table 91 Uk: Digital Therapeutics Market For B2b Sales Channel, Bybuyer, 2020–2027 (Usd Million)
8.3.3 France
8.3.3.1 Growing Healthcare Expenditure And Favorable Health Insurance System To Support Market
Table 92 France: Digital Therapeutics Market, By Application, 2020–2027(Usd Million)
Table 93 France: Digital Therapeutics Market For Treatment/Care-Related Applications, By Type, 2020–2027 (Usd Million)
Table 94 France: Digital Therapeutics Market For Preventiveapplications, By Type, 2020–2027 (Usd Million)
Table 95 France: Digital Therapeutics Market For Cns Disorders, Bytype, 2020–2027 (Usd Million)
Table 96 France: Digital Therapeutics Market, By Sales Channel, 2020–2027 (Usd Million)
Table 97 France: Digital Therapeutics Market For B2c Sales Channel, Bybuyer, 2020–2027 (Usd Million)
Table 98 France: Digital Therapeutics Market For B2b Sales Channel, Bybuyer, 2020–2027 (Usd Million)
8.3.4 Spain
8.3.4.1 Initiatives By Emerging Digital Therapeutics Startups To Drive Market
Table 99 Spain: Digital Therapeutics Market, By Application, 2020–2027(Usd Million)
Table 100 Spain: Digital Therapeutics Market For Treatment/Care-Related Applications, By Type, 2020–2027 (Usd Million)
Table 101 Spain: Digital Therapeutics Market For Preventiveapplications, By Type, 2020–2027 (Usd Million)
Table 102 Spain: Digital Therapeutics Market For Cns Disorders, Bytype, 2020–2027 (Usd Million)
Table 103 Spain: Digital Therapeutics Market, By Sales Channel, 2020–2027(Usd Million)
Table 104 Spain: Digital Therapeutics Market For B2c Sales Channel, Bybuyer, 2020–2027 (Usd Million)
Table 105 Spain: Digital Therapeutics Market For B2b Sales Channel, Bybuyer, 2020–2027 (Usd Million)
8.3.5 Italy
8.3.5.1 Need For Alternative And Effective Treatment To Drive Market
Table 106 Italy: Digital Therapeutics Market, By Application, 2020–2027(Usd Million)
Table 107 Italy: Digital Therapeutics Market For Treatment/Care-Related Applications, By Type, 2020–2027 (Usd Million)
Table 108 Italy: Digital Therapeutics Market For Preventiveapplications, By Type, 2020–2027 (Usd Million)
Table 109 Italy: Digital Therapeutics Market For Cns Disorders, By Type,2020–2027 (Usd Million)
Table 110 Italy: Digital Therapeutics Market, By Sales Channel, 2020–2027(Usd Million)
Table 111 Italy: Digital Therapeutics Market For B2c Sales Channel, Bybuyer, 2020–2027 (Usd Million)
Table 112 Italy: Digital Therapeutics Market For B2b Sales Channel, Bybuyer, 2020–2027 (Usd Million)
8.3.6 Rest Of Europe
Table 113 Roe: Digital Therapeutics Market, By Application, 2020–2027 (Usdmillion)
Table 114 Roe: Digital Therapeutics Market For Treatment/Care-Relatedapplications, By Type, 2020–2027 (Usd Million)
Table 115 Roe: Digital Therapeutics Market For Preventive Applications, Bytype, 2020–2027 (Usd Million)
Table 116 Roe: Digital Therapeutics Market For Cns Disorders, By Type, 2020–2027 (Usd Million)
Table 117 Roe: Digital Therapeutics Market, By Sales Channel, 2020–2027 (Usdmillion)
Table 118 Roe: Digital Therapeutics Market For B2c Sales Channel, By Buyer,2020–2027 (Usd Million)
Table 119 Roe: Digital Therapeutics Market For B2b Sales Channel, By Buyer,2020–2027 (Usd Million)
8.4 Asia Pacific
Table 120 Apac: Digital Therapeutics Market, By Country, 2020–2027 (Usd Million)
Table 121 Apac: Digital Therapeutics Market, By Application, 2020–2027 (Usd Million)
Table 122 Apac: Digital Therapeutics Market For Treatment/Care-Relatedapplications, By Type, 2020–2027 (Usd Million)
Table 123 Apac: Digital Therapeutics Market For Preventive Applications, By Type,2020–2027 (Usd Million)
Table 124 Apac: Digital Therapeutics Market For Cns Disorders, By Type, 2020–2027(Usd Million)
Table 125 Apac: Digital Therapeutics Market, By Sales Channel, 2020–2027 (Usdmillion)
Table 126 Apac: Digital Therapeutics Market For B2c Sales Channel, By Buyer, 2020–2027 (Usd Million)
Table 127 Apac: Digital Therapeutics Market For B2b Sales Channel, By Buyer, 2020–2027 (Usd Million)
8.4.1 Japan
8.4.1.1 Rising Diabetes Incidence And Collaborations To Drive Market Growth
Table 128 Japan: Digital Therapeutics Market, By Application, 2020–2027(Usd Million)
Table 129 Japan: Digital Therapeutics Market For Treatment/Care-Related Applications, By Type, 2020–2027 (Usd Million)
Table 130 Japan: Digital Therapeutics Market For Preventiveapplications, By Type, 2020–2027 (Usd Million)
Table 131 Japan: Digital Therapeutics Market For Cns Disorders, Bytype, 2020–2027 (Usd Million)
Table 132 Japan: Digital Therapeutics Market, By Sales Channel, 2020–2027 (Usd Million)
Table 133 Japan: Digital Therapeutics Market For B2c Sales Channel, Bybuyer, 2020–2027 (Usd Million)
Table 134 Japan: Digital Therapeutics Market For B2b Sales Channel, Bybuyer, 2020–2027 (Usd Million)
8.4.2 China
8.4.2.1 Growing Geriatric Population And Incidence Of Chronic Conditions To Drive Demand
Table 135 China: Digital Therapeutics Market, By Application, 2020–2027(Usd Million)
Table 136 China: Digital Therapeutics Market For Treatment/Care-Related Applications, By Type, 2020–2027 (Usd Million)
Table 137 China: Digital Therapeutics Market For Preventiveapplications, By Type, 2020–2027 (Usd Million)
Table 138 China: Digital Therapeutics Market For Cns Disorders, Bytype, 2020–2027 (Usd Million)
Table 139 China: Digital Therapeutics Market, By Sales Channel, 2020–2027 (Usd Million)
Table 140 China: Digital Therapeutics Market For B2c Sales Channel, Bybuyer, 2020–2027 (Usd Million)
Table 141 China: Digital Therapeutics Market For B2b Sales Channel, Bybuyer, 2020–2027 (Usd Million)
8.4.3 India
8.4.3.1 Rising Chronic Disease Incidence And Need For Better Disease Management To Drive Market
Table 142 India: Digital Therapeutics Market, By Application, 2020–2027(Usd Million)
Table 143 India: Digital Therapeutics Market For Treatment/Care-Related Applications, By Type, 2020–2027 (Usd Million)
Table 144 India: Digital Therapeutics Market For Preventiveapplications, By Type, 2020–2027 (Usd Million)
Table 145 India: Digital Therapeutics Market For Cns Disorders, By Type,2020–2027 (Usd Million)
Table 146 India: Digital Therapeutics Market, By Sales Channel, 2020–2027(Usd Million)
Table 147 India: Digital Therapeutics Market For B2c Sales Channel, Bybuyer, 2020–2027 (Usd Million)
Table 148 India: Digital Therapeutics Market For B2b Sales Channel, Bybuyer, 2020–2027 (Usd Million)
8.4.4 Rest Of Asia Pacific
Table 149 Roapac: Digital Therapeutics Market, By Application, 2020–2027 (Usdmillion)
Table 150 Roapac: Digital Therapeutics Market For Treatment/Care-Relatedapplications, By Type, 2020–2027 (Usd Million)
Table 151 Roapac: Digital Therapeutics Market For Preventive Applications,By Type, 2020–2027 (Usd Million)
Table 152 Roapac: Digital Therapeutics Market For Cns Disorders, By Type,2020–2027 (Usd Million)
Table 153 Roapac: Digital Therapeutics Market, By Sales Channel, 2020–2027 (Usd Million)
Table 154 Roapac Digital Therapeutics Market For B2c Sales Channel, Bybuyer, 2020–2027 (Usd Million)
Table 155 Roapac: Digital Therapeutics Market For B2b Sales Channel, Bybuyer, 2020–2027 (Usd Million)
8.5 Rest Of The World
Table 156 Row: Digital Therapeutics Market, By Application, 2020–2027 (Usd Million)
Table 157 Row: Digital Therapeutics Market For Treatment/Care-Relatedapplications, By Type, 2020–2027 (Usd Million)
Table 158 Row: Digital Therapeutics Market For Preventive Applications, By Type,2020–2027 (Usd Million)
Table 159 Row: Digital Therapeutics Market For Cns Disorders, By Type, 2020–2027(Usd Million)
Table 160 Row: Digital Therapeutics Market, By Sales Channel, 2020–2027 (Usdmillion)
Table 161 Row: Digital Therapeutics Market For B2c Sales Channel, By Buyer, 2020–2027 (Usd Million)
Table 162 Row: Digital Therapeutics Market For B2b Sales Channel, By Buyer, 2020–2027 (Usd Million)

9 Competitive Landscape
9.1 Overview
9.2 Key Player Strategies/Right To Win
Figure 28 Overview Of Strategies Adopted By Players In Digital Therapeutics
9.3 Market Share Analysis
Table 163 Digital Therapeutics Market: Degree Of Competition
Figure 29 Market Share Analysis: Digital Therapeutics Market
9.4 Market Ranking Analysis, 2022
Figure 30 Digital Therapeutics Market Ranking Analysis, 2022
9.5 Competitive Benchmarking
Table 164 Digital Therapeutics Market: Competitive Benchmarking Of Key Players
Table 165 Digital Therapeutics Market: Sales Channel Footprint Of Key Players
Table 166 Digital Therapeutics Market: Regional Footprint Of Key Players
9.5.1 Company Evaluation Matrix: Definitions And Methodology
Table 167 Digital Therapeutics Market: Criteria Considered For Evaluation
9.5.1.1 Stars
9.5.1.2 Emerging Leaders
9.5.1.3 Pervasive Players
9.5.1.4 Participants
Figure 31 Digital Therapeutics Market: Global Competitive Leadershipmapping, 2022
9.5.2 Competitive Leadership Mapping: Start-Ups/Smes (2022)
9.5.2.1 Progressive Companies
9.5.2.2 Starting Blocks
9.5.2.3 Responsive Companies
9.5.2.4 Dynamic Companies
Figure 32 Digital Therapeutics Market: Competitive Leadership Mappingfor Start-Ups/Smes, 2022
9.6 Competitive Scenario
Table 168 Key Product Launches And Approvals, January 2019– August 2022
9.6.1 Deals
Table 169 Digital Therapeutics Market: Deals, January 2019 - August 2022
9.6.2 Other Developments
Table 170 Digital Therapeutics Market: Other Developments, January 2019 -August 2022

10 Company Profiles
10.1 Key Players
(Business Overview, Products Offered, Recent Developments, And Mnm View (Key Strengths/Right To Win,Strategic Choices Made, And Weaknesses And Competitive Threats))*
10.1.1 Noom
Table 171 Noom: Business Overview
10.1.2 Teladoc Health
Table 172 Teladoc Health: Business Overview
Figure 33 Teladoc Health: Company Snapshot (2021)
10.1.3 Omada Health
Table 173 Omada Health: Business Overview
10.1.4 Welldoc
Table 174 Welldoc: Business Overview
10.1.5 Pear Therapeutics
Table 175 Pear Therapeutics: Business Overview
10.1.6 Cognifit
Table 176 Cognifit: Business Overview
10.1.7 Ginger
Table 177 Ginger: Business Overview
10.1.8 Propeller Health
Table 178 Propeller Health: Business Overview
10.1.9 2morrow
Table 179 2morrow: Business Overview
10.1.10 Canary Health
Table 180 Canary Health: Business Overview
10.1.11 Click Therapeutics
Table 181 Click Therapeutics: Business Overview
10.1.12 Akili
Table 182 Akili: Business Overview
10.1.13 Wellthy Therapeutics
Table 183 Wellthy Therapeutics: Business Overview
10.1.14 Cognoa
Table 184 Cognoa: Business Overview
10.1.15 Twill
Table 185 Twill: Business Overview
10.1.16 Kaia Health
Table 186 Kaia Health: Business Overview
10.1.17 Better Therapeutics
Table 187 Better Therapeutics: Business Overview
10.1.18 Mindstrong Health
Table 188 Mindstrong Health: Business Overview
10.1.19 Behavr
Table 189 Behavr: Business Overview
10.1.20 Ayogo
Table 190 Ayogo: Business Overview
10.2 Other Players
10.2.1 Mindable Health
10.2.2 Virta Health Corp
10.2.3 Hinge Health
10.2.4 Orexo Ab
10.2.5 Freespira
*Details On Business Overview, Products Offered, Recent Developments, And Mnm View (Key Strengths/Right Towin, Strategic Choices Made, And Weaknesses And Competitive Threats) Might Not Be Captured In Case Ofunlisted Companies.

11 Appendix
11.1 Discussion Guide
11.2 Knowledgestore: Marketsandmarkets’ Subscription Portal
11.3 Customization Options
11.4 Related Reports
11.5 Author Details

  • Global Healthcare Workforce Management System Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 86
    Workforce management is an institutional process that maximizes performance levels and competency for an organization. The process includes all The activities needed to maintain a productive workforce, such as field service management, human resource management, performance and training management, data collection, recruiting, budgeting, forecasting, scheduling and analytics. Workforce management provides a common set of performance-based tools and software to support corporate mana......
  • Global Life Science Analytics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Life Science Analytics market size was valued at US$ 23410 million in 2023. With growing demand in downstream market, the Life Science Analytics is forecast to a readjusted size of US$ 47330 million by 2030 with a CAGR of 10.6% during review period. The research report highlights the growth potential of the global Life Science Analytics market. Life Science Analytics are expected to show stable growth in the future market. Ho......
  • Global Patient Engagement Solutions Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Patient Engagement Solutions market size was valued at US$ 14090 million in 2023. With growing demand in downstream market, the Patient Engagement Solutions is forecast to a readjusted size of US$ 53040 million by 2030 with a CAGR of 20.9% during review period. The research report highlights the growth potential of the global Patient Engagement Solutions market. Patient Engagement Solutions are expected to show stable growth ......
  • Global Operating Room Management Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Operating Room Management market size was valued at US$ 4314.6 million in 2023. With growing demand in downstream market, the Operating Room Management is forecast to a readjusted size of US$ 6494.7 million by 2030 with a CAGR of 6.0% during review period. The research report highlights the growth potential of the global Operating Room Management market. Operating Room Management are expected to show stable growth in the futu......
  • Global Healthcare Supply Chain Managements Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Healthcare Supply Chain Managements market size was valued at US$ 2151.2 million in 2023. With growing demand in downstream market, the Healthcare Supply Chain Managements is forecast to a readjusted size of US$ 4098.9 million by 2030 with a CAGR of 9.6% during review period. The research report highlights the growth potential of the global Healthcare Supply Chain Managements market. Healthcare Supply Chain Managements are ex......
  • Global Healthcare Workforce Management System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Healthcare Workforce Management System market size was valued at US$ 1543.3 million in 2023. With growing demand in downstream market, the Healthcare Workforce Management System is forecast to a readjusted size of US$ 3331.2 million by 2030 with a CAGR of 11.6% during review period. The research report highlights the growth potential of the global Healthcare Workforce Management System market. Healthcare Workforce Management ......
  • Global Behavioral Health Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Behavioral Health Software market size was valued at US$ 1641 million in 2023. With growing demand in downstream market, the Behavioral Health Software is forecast to a readjusted size of US$ 3274.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Behavioral Health Software market. Behavioral Health Software are expected to show stable growth in the f......
  • Global Long-term Care Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Long-term Care Software market size was valued at US$ 1339.2 million in 2023. With growing demand in downstream market, the Long-term Care Software is forecast to a readjusted size of US$ 3460.2 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Long-term Care Software market. Long-term Care Software are expected to show stable growth in the future mark......
  • Global Healthcare RCM Outsourcing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Healthcare RCM Outsourcing market size was valued at US$ 19580 million in 2023. With growing demand in downstream market, the Healthcare RCM Outsourcing is forecast to a readjusted size of US$ 40390 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Healthcare RCM Outsourcing market. Healthcare RCM Outsourcing are expected to show stable growth in the f......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs